LEADIANT BIOSCIENCES, INC
LEADIANT BIOSCIENCES, INC appears in FDA public data with 4 recalls, 0 510(k) clearances, 1 FDA inspection, and 0 compliance actions on record. Its most recent recall (D-0327-2023, Class II) was initiated on February 3, 2023.
Summary
- Total Recalls
- 4
- 510(k) Clearances
- 0
- Inspections
- 1
- Compliance Actions
- 0
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0327-2023 | Class II | Abelcet (Amphotericin B Lipid Complex) Injection, 5 mg/mL, 100 mg vial, Rx only, Manufactured by Exe | February 3, 2023 |
| D-0034-2021 | Class III | Cystaran (cysteamine ophthalmic solution) 0.44%, For Ophthalmic Use Only, 15 mL bottle, Sterile, Rx | September 24, 2020 |
| D-0683-2018 | Class III | Cystaran (cysteamine ophthalmic solution) 0.44%, 15 mL bottle, Rx only, Manufactured by Hi-Tech Phar | April 9, 2018 |
| D-0550-2018 | Class III | Cystaran (cysteamine ophthalmic solution) 0.44%, 15 mL bottle, Rx only, Manufactured by Hi-Tech Phar | February 14, 2018 |